
New ABPI president appointed
pharmafile | April 30, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | ABPI, MSD UK, appointment
Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the British Pharmaceutical Industry (ABPI) after his recent election.
He gave his first public speech to the ABPI annual conference on Thursday 26 April, in which he thanked his predecessor and discussed the future challenges for industry.
He takes over from Simon Jose of GSK, and will serve for one year with the option of standing for re-election in a year’s time.
Deepak said: “It is a real honour to be serving the UK pharmaceutical industry and I am excited to be starting my work as president and leading the ABPI for the year to come.
“I would like to thank Simon Jose for his tireless work and for the great strides he has made to help modernise the ABPI, which I hope to build on.”
Commenting on Deepak’s appointment, Stephen Whitehead, chief executive of the ABPI, said:
“I am looking forward to working with Deepak to take not only the ABPI forward, but industry as a whole.
“I want to thank Simon Jose personally for his time as president – he was a powerful advocate for the pharmaceutical industry and he leaves behind a great legacy.”
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

The November 2020 issue of Pharmafocus is available to read free online now!
The latest monthly edition of Pharmafocus is available to read for free online now!

UK life sciences industry does not want no-deal Brexit, says ABPI Chief
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …






